Skip to content
  • Home
  • Journalists
    • Headlines
  • Community
    • Businesses
    • Jobs
    • Learning
    • Marketplace
  • Store
(@)

U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs

In an unusual court trial, a federal jury sided with the drug maker Gilead Sciences in a dispute over who came up with the idea of using a daily pill to prevent H.I.V.

Rebecca Robbins
Author: Rebecca Robbins

Written by

Rebecca Robbins

in

Centers for Disease Control and Prevention, Compensation for Damages (Law), Decisions and Verdicts, Drugs (Pharmaceuticals), Gilead Sciences Inc, Health and Human Services Department, Inventions and Patents, Suits and Litigation (Civil)
←Fox Producer Dismisses, for Now, Case Accusing Network of Coercion
How Wall Street Is Preparing for a Debt Ceiling Showdown→

More posts

  • Zhu Rongji, Former Premier Who Pushed China to a Market Economy, Dies at 97

  • Ariana Grande Spotted For First Time Since Announcing Plans To Step Back From Public Life

  • Six things to know about Marco Rubio’s joint interview with wife Jeanette on Katie Miller’s podcast

  • Lindell hits snooze on primary loss; progressive steam stalls

About Us


Support Us

Trademark & Copyright 1998 – 2025 · MOSAEC

  • Facebook
  • Instagram
  • LinkedIn
  • YouTube